"Drug Delivery Systems - Optimizing drug transport to
the site of action"

 
     
 

Developing tumor-specific delivery systems for analgetics (NSAIDs): high local dose for more effective tumor killing and less toxicity for the patient

Design and evaluation of tumor-specific gene therapy vectors (adeno-, retro- or herpesvirus-based)

Drug delivery systems steer the selective delivery of drugs to the site of action at the optimal rate

Screening and evaluation of novel gene and protein delivery systems such as retroviral expression vectors.


Exploiting immunoliposomes for site directed delivery of therapeutic agents (e.g. chemokine receptor antagonists, TFOs, siRNAs as well as DNA and RNA expressing vectors).